CLS Holdings USA focuses on the extraction of various cannabinoids from the marijuana plant and conversion into concentrates, such as oils, waxes, edibles, and shatters for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories.
CLS is another fully integrated cannabis company that we think has potential. The company is executing a roll-up and consolidation strategy which will help it build an underlying cash-flow business to support it’s medical R&D efforts with its proprietary method of extracting various cannabinoids from the marijuana plant.
The company successfully completed the acquisition of Oasis Cannabis dispensary in June of 2018, giving CLS an asset generating $850,000 in monthly revenue. CLS plans to triple the production capacity over the remainder of 2018, and if successful Oasis will give CLS a strong foothold in the Las Vegas cannabis market.